Quarterly Result27 Oct 2026, 10:47 am
OneSource Q2FY27 Revenue Up 37%, EBITDA Up 53%
AI Summary
OneSource Specialty Pharma Ltd reported a strong Q2FY27 with revenue reaching ₹5,162 million, a 37% increase year-on-year and 15% quarter-on-quarter. EBITDA surged by 53% YoY to ₹1,633 million, with margins expanding to 31.6%. Adjusted PAT stood at ₹937 million, up 109% YoY. The company attributes the growth to new DDC capacity, strong MSA execution, and multiple product launches. The CEO highlighted upcoming launches in H2 and continued momentum in biologics, with a new US biotech client onboarded. Additional capacity and partnerships are expected to drive future growth.
Key Highlights
- Revenue grew 37% YoY to ₹5,162 million.
- EBITDA increased 53% YoY to ₹1,633 million.
- EBITDA margins expanded to 31.6%.
- Adjusted PAT rose 109% YoY to ₹937 million.
- New capacity and product launches drove performance.
Price Impact
More from ONESOURCE